Aileron Therapeutics Inc (ALRN)
3.51
-0.15
(-4.10%)
USD |
NASDAQ |
May 24, 16:00
3.57
+0.06
(+1.71%)
After-Hours: 20:00
Aileron Therapeutics Total Liabilities (Quarterly): 54.44M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 54.44M |
December 31, 2023 | 99.12M |
September 30, 2023 | 1.624M |
June 30, 2023 | 1.197M |
March 31, 2023 | 2.884M |
December 31, 2022 | 3.384M |
September 30, 2022 | 4.536M |
June 30, 2022 | 5.151M |
March 31, 2022 | 4.146M |
December 31, 2021 | 4.577M |
September 30, 2021 | 4.659M |
June 30, 2021 | 4.401M |
March 31, 2021 | 3.252M |
December 31, 2020 | 4.179M |
September 30, 2020 | 9.781M |
Date | Value |
---|---|
June 30, 2020 | 9.471M |
March 31, 2020 | 10.60M |
December 31, 2019 | 10.42M |
September 30, 2019 | 11.14M |
June 30, 2019 | 10.21M |
March 31, 2019 | 9.552M |
December 31, 2018 | 10.71M |
September 30, 2018 | 12.10M |
June 30, 2018 | 9.709M |
March 31, 2018 | 4.856M |
December 31, 2017 | 4.891M |
September 30, 2017 | 5.023M |
June 30, 2017 | 135.88M |
March 31, 2017 | 2.875M |
December 31, 2016 | 133.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.197M
Minimum
Jun 2023
99.12M
Maximum
Dec 2023
12.96M
Average
4.618M
Median
Total Liabilities (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | 79.31M |
INVO Bioscience Inc | 18.31M |
Bio-Path Holdings Inc | 4.393M |
SINTX Technologies Inc | 7.635M |
NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 99.19M |
Shareholders Equity (Quarterly) | 44.75M |